Surgery may be a treatment for stage 1, 2, or 3 non-small cell lung cancer tumors. We may give chemotherapy with or without immunotherapy, before or after surgery.
Our medical oncologists (cancer doctors) work closely with other experts to design the best treatment plan. They include your surgeon, radiation oncologist, and pathologist.
Together, they’ll decide if adding chemotherapy is right for you. You may have it with or without immunotherapy, before or after surgery.
Tumors already may have spread when you first learn you have non-small cell lung cancer.
The cancer may have spread locally in the lung. Or, your surgeon may feel they cannot safely remove the cancer. If so, we may recommend chemotherapy along with radiation therapy. You also may have immunotherapy.
Tumors can come back even if they were removed during surgery or killed by radiation therapy. This happens if very tiny cancer cells travel from the primary tumor to other areas.
In some cases, the cancer spreads to other areas, such as the other lung or other parts of your body. We may recommend chemotherapy alone, or with immunotherapy.
MSK will test your tumor to get information about any genetic changes (mutations or variants). Genomic testing tells us which mutations caused the lung cancer and makes it grow and spread.
There may be a genetic change in the tumor that we can target with a treatment. This method is called targeted therapy. It’s a personal treatment just for the type of cancer you have. Targeted therapies are also called personal medicine, precision medicine, or precision oncology.